Ginevra Lolli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Haploidentical allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma in the era of novel agents: a single-center experience.
Journal: Leukemia & lymphoma
Published: March 05, 2026
Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma.
Journal: Annals of hematology
Published: May 14, 2025
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T-cell pathway in patients with diffuse large B-cell lymphoma.
Journal: Hematological oncology
Published: July 13, 2023
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report.
Journal: Chemotherapy
Published: July 25, 2022
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient.
Journal: Leukemia & lymphoma
Published: July 22, 2022
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
Journal: Frontiers in immunology
Published: July 15, 2022
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience.
Journal: Journal of cancer research and clinical oncology
Published: January 17, 2022
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience.
Journal: Cancers
Published: July 16, 2021
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report.
Journal: Tumori
Published: June 25, 2021
Last Updated: 09/26/2026